Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity. [electronic resource]
Producer: 20110825Description: 633-7 p. digitalISSN:- 1435-702X
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Female
- Humans
- Intravitreal Injections
- Male
- Prospective Studies
- Ranibizumab
- Recurrence
- Retina -- pathology
- Retreatment
- Time Factors
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vision Disorders -- physiopathology
- Visual Acuity -- physiology
- Wet Macular Degeneration -- diagnosis
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.